262.43
Amazon Com Inc stock is traded at $262.43, with a volume of 34.77M.
It is up +3.29% in the last 24 hours and up +2.20% over the past month.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 74% of total, followed by Amazon Web Services (17%), and advertising services (9%). International segments constitute 22% of Amazon's total revenue, led by Germany, the United Kingdom, and Japan.
See More
Previous Close:
$254.06
Open:
$256.5
24h Volume:
34.77M
Relative Volume:
0.98
Market Cap:
$2.83T
Revenue:
$742.78B
Net Income/Loss:
$90.80B
P/E Ratio:
31.36
EPS:
8.3676
Net Cash Flow:
$-2.47B
1W Performance:
+4.39%
1M Performance:
+2.20%
6M Performance:
+10.09%
1Y Performance:
+21.29%
Amazon Com Inc Stock (AMZN) Company Profile
Name
Amazon Com Inc
Sector
Industry
Phone
(206) 266-1000
Address
410 TERRY AVENUE NORTH, SEATTLE, WA
Compare AMZN vs BABA, PDD, MELI, DASH
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
AMZN
Amazon Com Inc
|
262.43 | 2.83T | 742.78B | 90.80B | -2.47B | 8.3676 |
|
BABA
Alibaba Group Holding Ltd Adr
|
111.37 | 277.06B | 144.18B | 14.66B | -7.14B | 6.1924 |
|
PDD
Pdd Holdings Inc Adr
|
81.35 | 115.79B | 62.32B | 13.62B | 15.10B | 9.1742 |
|
MELI
Mercadolibre Inc
|
1,889.85 | 95.81B | 31.80B | 1.92B | 8.56B | 37.87 |
|
DASH
Doordash Inc
|
196.50 | 85.14B | 14.72B | 923.00M | 1.75B | 2.0994 |
Amazon Com Inc Stock (AMZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-30-26 | Reiterated | Rosenblatt | Buy |
| Sep-03-26 | Reiterated | Wells Fargo | Overweight |
| Aug-28-26 | Reiterated | Evercore ISI | Outperform |
| Aug-20-26 | Resumed | Rosenblatt | Buy |
| Jul-31-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-31-26 | Reiterated | Citigroup | Buy |
| Jul-31-26 | Reiterated | Deutsche Bank | Buy |
| Jul-31-26 | Reiterated | Goldman | Buy |
| Jul-31-26 | Reiterated | JP Morgan | Overweight |
| Jul-31-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-31-26 | Reiterated | Mizuho | Outperform |
| Jul-31-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Jul-31-26 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-26 | Reiterated | Piper Sandler | Overweight |
| Jul-31-26 | Reiterated | Pivotal Research Group | Buy |
| Jul-31-26 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-31-26 | Reiterated | Raymond James | Outperform |
| Jul-31-26 | Reiterated | Robert W. Baird | Outperform |
| Jul-31-26 | Reiterated | TD Cowen | Buy |
| Jul-31-26 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-31-26 | Reiterated | The Benchmark Company | Buy |
| Jul-31-26 | Reiterated | UBS | Buy |
| Jul-31-26 | Reiterated | Wedbush | Outperform |
| Jul-31-26 | Reiterated | Wells Fargo | Overweight |
| Jul-16-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-16-26 | Resumed | Wedbush | Outperform |
| Jul-08-26 | Reiterated | TD Cowen | Buy |
| Jun-01-26 | Reiterated | Truist | Buy |
| May-20-26 | Reiterated | Wells Fargo | Overweight |
| Apr-30-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Goldman | Buy |
| Apr-30-26 | Reiterated | Guggenheim | Buy |
| Apr-30-26 | Reiterated | JP Morgan | Overweight |
| Apr-30-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-30-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-30-26 | Reiterated | Oppenheimer | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Pivotal Research Group | Buy |
| Apr-30-26 | Reiterated | Rosenblatt | Buy |
| Apr-30-26 | Reiterated | Stifel | Buy |
| Apr-30-26 | Reiterated | Susquehanna | Positive |
| Apr-30-26 | Reiterated | TD Cowen | Buy |
| Apr-30-26 | Reiterated | Telsey Advisory Group | Outperform |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | UBS | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-30-26 | Reiterated | Wolfe Research | Outperform |
| Apr-24-26 | Reiterated | Oppenheimer | Outperform |
| Apr-20-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-17-26 | Reiterated | Truist | Buy |
| Apr-07-26 | Reiterated | MoffettNathanson | Buy |
| Mar-25-26 | Reiterated | JP Morgan | Overweight |
| Feb-23-26 | Reiterated | Wells Fargo | Overweight |
| Feb-06-26 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-06-26 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-02-26 | Reiterated | Citizens JMP | Mkt Outperform |
| Jan-28-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-28-26 | Reiterated | Oppenheimer | Outperform |
| Jan-27-26 | Reiterated | BofA Securities | Buy |
| Jan-27-26 | Reiterated | Stifel | Buy |
| Jan-15-26 | Reiterated | Raymond James | Outperform |
| Jan-13-26 | Reiterated | TD Cowen | Buy |
| Jan-12-26 | Reiterated | Wells Fargo | Overweight |
| Jan-08-26 | Reiterated | Cantor Fitzgerald | Overweight |
| Jan-05-26 | Reiterated | Jefferies | Buy |
| Dec-02-25 | Reiterated | Wells Fargo | Overweight |
| Dec-01-25 | Reiterated | Oppenheimer | Outperform |
| Nov-24-25 | Initiated | BNP Paribas Exane | Outperform |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-04-25 | Reiterated | Mizuho | Outperform |
| Oct-31-25 | Reiterated | Evercore ISI | Outperform |
| Oct-31-25 | Reiterated | JP Morgan | Overweight |
| Oct-31-25 | Reiterated | KeyBanc Capital Markets | Overweight |
| Oct-31-25 | Reiterated | Monness Crespi & Hardt | Buy |
| Oct-31-25 | Reiterated | Morgan Stanley | Overweight |
| Oct-31-25 | Reiterated | Oppenheimer | Outperform |
| Oct-31-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-25 | Reiterated | Pivotal Research Group | Buy |
| Oct-31-25 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-31-25 | Reiterated | Robert W. Baird | Outperform |
| Oct-31-25 | Reiterated | Rosenblatt | Buy |
| Oct-31-25 | Reiterated | Roth Capital | Buy |
| Oct-31-25 | Reiterated | Seaport Research Partners | Buy |
| Oct-31-25 | Reiterated | Stifel | Buy |
| Oct-31-25 | Reiterated | Susquehanna | Positive |
| Oct-31-25 | Reiterated | TD Cowen | Buy |
| Oct-31-25 | Reiterated | Telsey Advisory Group | Outperform |
| Oct-31-25 | Reiterated | The Benchmark Company | Buy |
| Oct-31-25 | Reiterated | UBS | Buy |
| Oct-31-25 | Reiterated | Wells Fargo | Overweight |
| Oct-24-25 | Resumed | KeyBanc Capital Markets | Overweight |
| Oct-03-25 | Reiterated | Goldman | Buy |
| Sep-30-25 | Initiated | Mizuho | Outperform |
| Sep-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Sep-16-25 | Reiterated | Truist | Buy |
| Aug-01-25 | Reiterated | Barclays | Overweight |
| Aug-01-25 | Reiterated | BofA Securities | Buy |
| Aug-01-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Aug-01-25 | Reiterated | Citigroup | Buy |
| Aug-01-25 | Reiterated | DA Davidson | Buy |
| Aug-01-25 | Reiterated | JP Morgan | Overweight |
| Aug-01-25 | Reiterated | Monness Crespi & Hardt | Buy |
| Aug-01-25 | Reiterated | Oppenheimer | Outperform |
| Aug-01-25 | Reiterated | Piper Sandler | Overweight |
| Aug-01-25 | Reiterated | Pivotal Research Group | Buy |
| Aug-01-25 | Reiterated | Stifel | Buy |
| Aug-01-25 | Reiterated | Susquehanna | Positive |
| Aug-01-25 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-30-25 | Reiterated | Wedbush | Outperform |
| Jul-29-25 | Reiterated | Stifel | Buy |
| Jul-29-25 | Reiterated | Wells Fargo | Equal Weight |
| Jul-28-25 | Reiterated | UBS | Buy |
| Jul-23-25 | Reiterated | BofA Securities | Buy |
| Jul-22-25 | Reiterated | Needham | Buy |
| Jul-21-25 | Reiterated | Robert W. Baird | Outperform |
| Jul-11-25 | Reiterated | JP Morgan | Overweight |
| Jul-10-25 | Resumed | Citizens JMP | Mkt Outperform |
| Jul-08-25 | Reiterated | Wells Fargo | Equal Weight |
| Jul-02-25 | Reiterated | Truist | Buy |
| Jun-27-25 | Upgrade | BNP Paribas Exane | Neutral → Outperform |
| Jun-24-25 | Reiterated | MoffettNathanson | Buy |
| Apr-23-25 | Reiterated | Telsey Advisory Group | Outperform |
| Apr-22-25 | Reiterated | Jefferies | Buy |
| Apr-21-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Apr-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Apr-14-25 | Reiterated | Citigroup | Buy |
| Apr-14-25 | Reiterated | Citizens JMP | Mkt Outperform |
| Apr-14-25 | Reiterated | Deutsche Bank | Buy |
| Apr-14-25 | Reiterated | Morgan Stanley | Overweight |
| Jan-27-25 | Reiterated | Wedbush | Outperform |
| Jan-06-25 | Reiterated | Wedbush | Outperform |
| Jan-03-25 | Reiterated | Wolfe Research | Outperform |
| Dec-16-24 | Reiterated | UBS | Buy |
| Nov-14-24 | Reiterated | Needham | Buy |
| Nov-01-24 | Reiterated | Monness Crespi & Hardt | Buy |
| Nov-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Oct-16-24 | Reiterated | Loop Capital | Buy |
| Oct-11-24 | Initiated | Pivotal Research Group | Buy |
| Oct-11-24 | Initiated | Scotiabank | Sector Outperform |
| Oct-09-24 | Reiterated | Cantor Fitzgerald | Overweight |
| Oct-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Sep-05-24 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-02-24 | Downgrade | Itau BBA | Outperform → Market Perform |
| Aug-02-24 | Reiterated | Maxim Group | Buy |
| Jul-30-24 | Reiterated | UBS | Buy |
| Jul-17-24 | Reiterated | Needham | Buy |
| Jul-16-24 | Reiterated | Goldman | Buy |
| Jul-16-24 | Initiated | Wolfe Research | Outperform |
| Jul-10-24 | Reiterated | TD Cowen | Buy |
| May-01-24 | Reiterated | Maxim Group | Buy |
| May-01-24 | Reiterated | Monness Crespi & Hardt | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Apr-17-24 | Initiated | Maxim Group | Buy |
| Apr-17-24 | Reiterated | Truist | Buy |
| Feb-02-24 | Reiterated | JMP Securities | Mkt Outperform |
| Feb-02-24 | Reiterated | JP Morgan | Overweight |
| Feb-02-24 | Reiterated | Mizuho | Buy |
| Feb-02-24 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-02-24 | Reiterated | Morgan Stanley | Overweight |
| Feb-02-24 | Reiterated | Needham | Buy |
| Feb-02-24 | Reiterated | Oppenheimer | Outperform |
| Feb-02-24 | Reiterated | Piper Sandler | Overweight |
| Feb-02-24 | Reiterated | ROTH MKM | Buy |
| Feb-02-24 | Reiterated | Raymond James | Strong Buy |
| Feb-02-24 | Reiterated | Robert W. Baird | Outperform |
| Feb-02-24 | Reiterated | Seaport Research Partners | Buy |
| Feb-02-24 | Reiterated | Stifel | Buy |
| Feb-02-24 | Reiterated | Susquehanna | Positive |
| Feb-02-24 | Reiterated | TD Cowen | Outperform |
| Feb-02-24 | Reiterated | Telsey Advisory Group | Outperform |
| Feb-02-24 | Reiterated | The Benchmark Company | Buy |
| Feb-02-24 | Reiterated | Wedbush | Outperform |
| Feb-02-24 | Reiterated | Wells Fargo | Overweight |
| Feb-02-24 | Reiterated | Wolfe Research | Outperform |
| Jan-24-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jan-17-24 | Reiterated | Wells Fargo | Overweight |
| Jan-09-24 | Initiated | BMO Capital Markets | Outperform |
| Jan-03-24 | Resumed | DA Davidson | Buy |
| Dec-22-23 | Reiterated | Needham | Buy |
| Dec-20-23 | Resumed | Raymond James | Strong Buy |
| Dec-18-23 | Reiterated | ROTH MKM | Buy |
| Dec-14-23 | Reiterated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | HSBC Securities | Buy |
| Oct-24-23 | Initiated | Seaport Research Partners | Buy |
| Oct-17-23 | Initiated | Stifel | Buy |
| Aug-24-23 | Reiterated | Piper Sandler | Overweight |
| Aug-23-23 | Reiterated | Loop Capital | Buy |
| Aug-22-23 | Resumed | Wedbush | Outperform |
| Aug-11-23 | Reiterated | Redburn | Buy |
| Aug-04-23 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Aug-04-23 | Reiterated | JP Morgan | Overweight |
| Aug-04-23 | Reiterated | Mizuho | Buy |
| Aug-04-23 | Reiterated | Morgan Stanley | Overweight |
| Aug-04-23 | Reiterated | Needham | Buy |
| Aug-04-23 | Reiterated | ROTH MKM | Buy |
| Aug-04-23 | Reiterated | Robert W. Baird | Outperform |
| Aug-04-23 | Upgrade | Rosenblatt | Neutral → Buy |
| Aug-04-23 | Reiterated | Stifel | Buy |
| Aug-04-23 | Reiterated | Susquehanna | Positive |
| Aug-04-23 | Reiterated | TD Cowen | Outperform |
| Aug-04-23 | Reiterated | Telsey Advisory Group | Outperform |
| Aug-04-23 | Reiterated | The Benchmark Company | Buy |
| Aug-04-23 | Reiterated | Truist | Buy |
| Aug-04-23 | Reiterated | UBS | Buy |
| Aug-04-23 | Reiterated | Wedbush | Outperform |
| Apr-24-23 | Reiterated | MoffettNathanson | Outperform |
| Apr-24-23 | Reiterated | UBS | Buy |
| Apr-18-23 | Reiterated | Deutsche Bank | Buy |
| Apr-06-23 | Reiterated | Oppenheimer | Outperform |
| Jan-30-23 | Reiterated | Barclays | Overweight |
| Jan-30-23 | Reiterated | Credit Suisse | Outperform |
| Jan-25-23 | Reiterated | UBS | Buy |
| Jan-24-23 | Reiterated | Telsey Advisory Group | Outperform |
| Jan-18-23 | Reiterated | MKM Partners | Buy |
| Jan-04-23 | Initiated | New Street | Buy |
| Nov-15-22 | Initiated | MoffettNathanson | Outperform |
| Oct-28-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Oct-28-22 | Reiterated | Morgan Stanley | Overweight |
| Oct-28-22 | Reiterated | Needham | Buy |
| Oct-28-22 | Reiterated | Oppenheimer | Outperform |
| Oct-28-22 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-28-22 | Reiterated | Raymond James | Outperform |
| Oct-28-22 | Reiterated | Robert W. Baird | Outperform |
| Oct-28-22 | Reiterated | Telsey Advisory Group | Outperform |
| Oct-28-22 | Reiterated | The Benchmark Company | Buy |
| Oct-28-22 | Reiterated | Truist | Buy |
| Oct-28-22 | Reiterated | Wedbush | Outperform |
| Oct-28-22 | Reiterated | Wells Fargo | Overweight |
| Oct-28-22 | Reiterated | Wolfe Research | Outperform |
| Jun-29-22 | Initiated | Redburn | Buy |
| Jun-01-22 | Resumed | JMP Securities | Mkt Outperform |
| Apr-29-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Apr-20-22 | Resumed | Citigroup | Buy |
| Apr-19-22 | Initiated | Rosenblatt | Neutral |
| Mar-29-22 | Initiated | Exane BNP Paribas | Underperform |
| Mar-11-22 | Initiated | Deutsche Bank | Buy |
| Feb-04-22 | Reiterated | Barclays | Overweight |
| Feb-04-22 | Reiterated | Canaccord Genuity | Buy |
| Feb-04-22 | Reiterated | Credit Suisse | Outperform |
| Feb-04-22 | Reiterated | Goldman | Buy |
| Feb-04-22 | Reiterated | JP Morgan | Overweight |
| Feb-04-22 | Reiterated | MKM Partners | Buy |
| Feb-04-22 | Reiterated | Piper Sandler | Overweight |
| Feb-04-22 | Reiterated | Raymond James | Outperform |
| Feb-04-22 | Reiterated | UBS | Buy |
| Feb-04-22 | Reiterated | Wolfe Research | Outperform |
| Dec-13-21 | Reiterated | Cowen | Outperform |
| Dec-02-21 | Resumed | UBS | Buy |
| Nov-23-21 | Resumed | Guggenheim | Buy |
| Oct-29-21 | Reiterated | Barclays | Overweight |
| Oct-29-21 | Reiterated | Credit Suisse | Outperform |
| Oct-29-21 | Reiterated | Evercore ISI | Outperform |
| Oct-29-21 | Reiterated | Jefferies | Buy |
| Oct-29-21 | Reiterated | Mizuho | Buy |
| Oct-29-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-29-21 | Reiterated | Piper Sandler | Overweight |
| Oct-29-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-29-21 | Reiterated | Raymond James | Outperform |
| Oct-29-21 | Reiterated | Telsey Advisory Group | Outperform |
| Oct-29-21 | Reiterated | The Benchmark Company | Buy |
| Oct-29-21 | Reiterated | Truist | Buy |
| Oct-29-21 | Reiterated | Wedbush | Outperform |
| Oct-29-21 | Reiterated | Wolfe Research | Outperform |
| Oct-22-21 | Reiterated | Credit Suisse | Outperform |
| Oct-07-21 | Reiterated | Cowen | Outperform |
| Oct-01-21 | Initiated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Reiterated | Morgan Stanley | Overweight |
| Sep-14-21 | Reiterated | Evercore ISI | Outperform |
| Sep-13-21 | Initiated | Goldman | Buy |
| Jul-30-21 | Reiterated | BMO Capital Markets | Outperform |
| Jul-30-21 | Reiterated | BofA Securities | Buy |
| Jul-30-21 | Reiterated | Cowen | Outperform |
| Jul-30-21 | Reiterated | Mizuho | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Raymond James | Outperform |
| Jul-30-21 | Reiterated | Susquehanna | Positive |
| Jul-30-21 | Reiterated | The Benchmark Company | Buy |
| Jul-30-21 | Reiterated | Truist | Buy |
| Apr-16-21 | Reiterated | Credit Suisse | Outperform |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Apr-01-21 | Initiated | Wolfe Research | Outperform |
| Feb-03-21 | Reiterated | Barclays | Overweight |
| Feb-03-21 | Reiterated | Canaccord Genuity | Buy |
| Feb-03-21 | Reiterated | Cowen | Outperform |
| Feb-03-21 | Reiterated | Credit Suisse | Outperform |
| Feb-03-21 | Reiterated | Deutsche Bank | Buy |
| Feb-03-21 | Reiterated | Goldman | Buy |
| Feb-03-21 | Reiterated | Guggenheim | Buy |
| Feb-03-21 | Reiterated | JP Morgan | Overweight |
| Feb-03-21 | Reiterated | Jefferies | Buy |
| Feb-03-21 | Reiterated | MKM Partners | Buy |
| Feb-03-21 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-03-21 | Reiterated | Oppenheimer | Outperform |
| Feb-03-21 | Reiterated | Pivotal Research Group | Buy |
| Feb-03-21 | Reiterated | Raymond James | Outperform |
| Feb-03-21 | Reiterated | Stifel | Buy |
| Feb-03-21 | Reiterated | Susquehanna | Positive |
| Feb-03-21 | Reiterated | UBS | Buy |
| Feb-03-21 | Reiterated | Wedbush | Outperform |
| Jan-22-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-20 | Upgrade | China Renaissance | Hold → Buy |
| Oct-30-20 | Reiterated | Monness Crespi & Hardt | Buy |
| Oct-07-20 | Reiterated | The Benchmark Company | Buy |
| Oct-01-20 | Reiterated | Pivotal Research Group | Buy |
| Sep-25-20 | Resumed | Piper Sandler | Overweight |
| Sep-22-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jul-31-20 | Reiterated | Canaccord Genuity | Buy |
| Jul-31-20 | Reiterated | Credit Suisse | Outperform |
| Jul-31-20 | Reiterated | Deutsche Bank | Buy |
| Jul-31-20 | Reiterated | JMP Securities | Mkt Outperform |
| Jul-31-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jul-31-20 | Reiterated | Mizuho | Buy |
| Jul-31-20 | Reiterated | Monness Crespi & Hardt | Buy |
| Jul-31-20 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-20 | Reiterated | Needham | Buy |
| Jul-31-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jul-31-20 | Reiterated | SunTrust | Buy |
| Jul-31-20 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-31-20 | Reiterated | UBS | Buy |
| Jul-31-20 | Reiterated | Wedbush | Outperform |
View All
Amazon Com Inc Stock (AMZN) Latest News
These 2 AI Stocks Have Stumbled. Now They May Soar Nearly 75%, According to Wall Street. - The Motley Fool
Following OpenAI’s Revenue Report, Should You Really Buy AI Stocks Right Now? - The Motley Fool
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor - The Motley Fool
If I Had a Choice to Invest $10,000 in SpaceX or Nvidia, Here's What I Would Do - The Motley Fool
Billionaire Ray Dalio Said The AI Bubble Is Close To Popping. Could SpaceX Be the Culpirit? - The Motley Fool
Where Will Credo Technology Be in 3 Years? - The Motley Fool
Caterpillar vs. Corning: Which Industrials Stock Is a Better Buy in 2026? - The Motley Fool
Better E-Commerce Stock: Coupang vs. Shopify - The Motley Fool
Better High-Growth AI Stock: CrowdStrike vs. Palantir Technologies - The Motley Fool
Cerebras Systems vs. IonQ: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Can IBM's Partnership With SAP for ERP Modernization Lift Its Shares? - Zacks Investment Research
Buy Cisco Systems as Leader of the AI Cloud Networking Space for 2027 - Zacks Investment Research
Amazon Just Signed a 20-Year Nuclear Power Deal. Here's the 1 Industrial Stock That Benefits Most. - The Motley Fool
Here's Why I Sold Cipher Digital and Bought More Iren - The Motley Fool
Guide to Magnificent Seven ETF investing - Zacks Investment Research
If You're Worried About an AI Bubble, Here's the Tech Stock Portfolio I'd Build - The Motley Fool
Michael Burry Is Betting Against Artificial Intelligence (AI). Here's the Case for and Against, and the One Stock I'd Still Own. - The Motley Fool
Zacks Investment Ideas feature highlights: Synopsys and Amazon - Zacks Investment Research
Nebius Group vs. SoundHound AI: Which Tech Stock Is a Better Buy in 2026? - The Motley Fool
THE CANINE PROJECT LAUNCHES FURVIVEBRINGING LUXURY SKINCARE INGREDIENTS TO DOG BATH DAY - GlobeNewswire Inc.
Synopsys (SNPS): The Next Big AI Stock Breakout? - Zacks Investment Research
Apple Rises 24% YTD: Should You Buy, Sell or Hold the AAPL Stock? - Zacks Investment Research
Anthropic Plans to Spend $518 Billion on Cloud and Computing Power - The Motley Fool
Alibaba Plunges 16.2% in 6 Months: 3 Key Reasons to Hold the Stock - Zacks Investment Research
Meet the Super Semiconductor Stock Crushing Nvidia in 2026 - The Motley Fool
1 Unstoppable Artificial Intelligence (AI) Stock to Buy Before It Joins Nvidia in the $5 Trillion Club - The Motley Fool
Can Microsoft's Big AI Capex Translate Into Sustainable Returns Ahead? - Zacks Investment Research
3 Glorious Growth Stocks to Buy Hand Over Fist if the Stock Market Crashes - The Motley Fool
Should iShares Russell 1000 Value ETF (IWD) Be on Your Investing Radar? - Zacks Investment Research
97 Billion Nvidia Partners Just Got a Strong Buy Endorsement (Hint: It's Not Palantir or Micron) - The Motley Fool
Taiwan Semiconductor Manufacturing Could Have Big News on Oct. 15 - The Motley Fool
Big Tech Keeps Signing Nuclear Deals With the Same Company. Here's Who It Is and Why That Matters More Than Any Single Deal. - The Motley Fool
BigBear.ai vs. IonQ: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
D-Wave Quantum vs. Rigetti Computing: Which Cutting Edge Quantum Stock Is a Better Buy in 2026? - The Motley Fool
SpaceX vs. Nvidia: Which Is the Better Trillion-Dollar Artificial Intelligence (AI) Stock for 2027? - The Motley Fool
Qualcomm vs. Taiwan Semiconductor Manufacturing: Which Technology Stock Is a Better Buy in 2026? - The Motley Fool
Netflix Stock Plunges 26.8% Year to Date: 3 Key Reasons to Stay Away - Zacks Investment Research
Is Amazon Stock Poised to Rally on AI Services Revenue Expansion? - Zacks Investment Research
Snowflake Stock Rallies 34% in a Year: Should You Buy, Sell, or Hold? - Zacks Investment Research
IBM Brings AI to Customer-Managed Infrastructure: Should You Invest? - Zacks Investment Research
Broadcom's AI Revenue Is Growing at 221%. Here's Why Custom Chips Could Be a Bigger Business Than GPUs. - The Motley Fool
The Emmys Are Moving to Amazon Prime Video — And You Won’t Need a Prime Subscription to Watch - Benzinga
Vancity Investment Management Ltd Sells 8,471 Shares of Amazon.com, Inc. $AMZN - MarketBeat
2,171 Amazon.com, Inc. $AMZN Shares Purchased by Wellington Grp LLC - MarketBeat
Amazon.com, Inc. $AMZN Stock Acquired by Range Advisory LLC - MarketBeat
Amazon.com, Inc. $AMZN Shares Newly Acquired by Schulz Wealth LTD. - MarketBeat
1,659,900 Shares of Amazon.com, Inc. $AMZN Bought by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Amazon.com, Inc. $AMZN Stock Holdings Trimmed by Kingsbury Capital Investment Advisors LLC - MarketBeat
2,853,182 Shares in Amazon.com, Inc. $AMZN Purchased by Nykredit A S - MarketBeat
Amazon.com, Inc. $AMZN Stake Raised by Formuepleje A S - MarketBeat
Amazon Com Inc Stock (AMZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Amazon Com Inc Stock (AMZN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Herrington Douglas J | CEO Worldwide Amazon Stores |
Sep 01 '26 |
Sale |
254.77 |
1,000 |
254,770 |
475,681 |
| DAY 1 ACADEMIES | Nonprofit founded by Jeffrey P |
Aug 27 '26 |
Proposed Sale |
256.57 |
230,637 |
59,174,627 |
0 |
| Zapolsky David | Officer |
Aug 24 '26 |
Proposed Sale |
259.77 |
9,258 |
2,404,951 |
0 |
| Zapolsky David | Senior Vice President |
Aug 24 '26 |
Sale |
259.77 |
9,258 |
2,404,951 |
41,190 |
| Garman Matthew S | CEO Amazon Web Services |
Aug 21 '26 |
Sale |
259.06 |
14,541 |
3,766,920 |
17,794 |
| Herrington Douglas J | CEO Worldwide Amazon Stores |
Aug 21 '26 |
Option Exercise |
0.00 |
15,905 |
0 |
483,043 |
| Herrington Douglas J | CEO Worldwide Amazon Stores |
Aug 21 '26 |
Sale |
259.01 |
6,362 |
1,647,810 |
476,681 |
| Zapolsky David | Senior Vice President |
Aug 21 '26 |
Option Exercise |
0.00 |
15,430 |
0 |
56,620 |
| Zapolsky David | Senior Vice President |
Aug 21 '26 |
Sale |
259.14 |
6,172 |
1,599,394 |
50,448 |
| Olsavsky Brian T | Senior Vice President and CFO |
Aug 21 '26 |
Option Exercise |
0.00 |
15,430 |
0 |
115,379 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):